WP
CRVO icon

Woodline Partners’s CervoMed CRVO Stock Holding History

Woodline Partners’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
+688,987
New +$2.43M 0.01% 830
2025
Q1 		– Sell
-74,852
Closed -$175K – 927
2024
Q4 		$175K Buy
+74,852
New +$728K ﹤0.01% 909

Other funds holding CRVO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

Woodline Partners's CRVO Position: Q2 2026 in Review

Woodline Partners opened a new position in CervoMed (CRVO) in Q2 2026: 688,987 shares worth $2.14M. The stake represents 0.01% of the portfolio and ranks #830 among its holdings. This is a return to the name: Woodline Partners previously reported a position in CRVO as recently as Q4 2024.

Woodline Partners first reported a position in CRVO in Q4 2024 and has held it in 2 quarters since. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Woodline Partners held 688,987 shares of CervoMed worth $2.14M as of Q2 2026.
  • CervoMed was a new Woodline Partners position in Q2 2026.
  • CervoMed made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #830 holding.
  • Woodline Partners first reported a position in CervoMed in Q4 2024 and has held it in 2 quarters since.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.